MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,600K
EPS
-$5.37
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
2,076
2,111
2,226*
2,585
Selling, general and administrative expenses
1,720
1,951
4,024*
2,298
Loss from operations
-3,796
-4,062
-6,250*
-4,883
Realized gains from sales of trading securities
209
238
502*
208
Unrealized loss from trading securities
-22
-43
-274*
-39
Interest income
9
22
167*
175
Loss from disposition of property and equipment
-
-4
-
-
Total other income
196
213
395*
344
Net loss
-3,600
-3,849
-5,855
-4,539
Basic EPS
-5.37
-5.89
0.309
-0.23
Diluted EPS
-5.37
-5.89
0.309
-0.23
Basic Average Shares
671,000
654,000
-18,977,000
20,155,000
Diluted Average Shares
671,000
654,000
-18,977,000
20,155,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Realized gains from sales
of trading...
$209K
Interest income
$9K
Net loss
-$3,600K
Total other income
$196K
Unrealized loss from
trading securities
-$22K
Loss from operations
-$3,796K
Research and development
expenses
$2,076K
Selling, general and
administrative expenses
$1,720K
Buy us a coffee
enVVeno Medical Corp (NVNO)
enVVeno Medical Corp (NVNO)